SARAH HYLAND: Open Payments
NPI 1467126763 · SALEM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 18 payments from 11 companies in 2025. Trend: 2023 $392 · 2024 $1,192 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: REXULTI, TRELEGY ELLIPTA, Auvelity, FARXIGA, JARDIANCE, ZEPBOUND, Ozempic, UBRELVY.
Industry payments across NY — which companies pay providers there.
